Skip to main content
Premium Trial:

Request an Annual Quote

Michael Liebman, Myra Williams, Michael Lack, David Clark

Premium

Michael Liebman is leaving his post as director of computational biology and biomedical informatics at the Abramson Cancer Center at the University of Pennsylvania to join the Windber Research Institute as chief scientific officer. Prior to joining the University of Pennsylvania, Liebman was global director of bioinformatics at Roche Bioscience.


ProSanos has appointed Myra Williams and Michael Lack to its board of directors. Williams, a consultant for pharmaceutical, biotechnology, IT, and bioinformatics companies, was formerly CIO for Glaxo and president and CEO of Molecular Applications Group. Lack is also a biotechnology and informatics consultant, and was most recently COO of Incyte Genomics (now Incyte).


David Clark, director of computer-aided drug design at Argenta Discovery, has been awarded the Corwin Hansch Award for his work on quantitative structure-activity relationships. The award — for scientists under 40 who have contributed significantly to QSAR — is presented by the QSAR and Modeling Society and consists of a citation and $1,000.

Filed under

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.